Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Living with dementia

vesanic dementia2 - vessel disease1 - cognition function1 - pet1 - moderate parkinson's disease1 - movement disorders1 - rates of dementia1 - pick's disease2 - alzheimer’s vaccine1 - alzheimer's drug5 - postoperative cognitive dysfunction1 - karl wernicke4 - hiv1 - quality standards subcommittee1 - symptoms of alzheimer's2 - symptoms of parkinson's disease1 - medicare1 - social withdrawal1 - degenerationist hypothesis1 - confabulatory euphoria1 - glucose hypometabolism1 - blood pressure6 - alcoholism1 - treat parkinson's1 - risk of stroke1 - bucknill1 - amyloid1 - risk of alzheimer's3 - prevent dementia4 - kahlbaum3 -